Home » Newsletters » BioWorld Science

BioWorld Science

April 17, 1997

View Archived Issues

Antiulcer activity of cromakalim

Capsaicin for neurogenic bladder dysfunction and interstitial cystitis

Topical herbal cream evaluated for premature ejaculation

Oxford Molecular Group launches drug discovery software tool

Vion's TAPET technology demonstrates potential to target and inhibit tumor growth

Novel bisphosphonates revealed by Yissum

Eisai/Janssen form strategic alliance for rabeprazole

Defibrillators associated with reduced mortality compared to antiarrhythmic drugs

SKB describes 5-HT2C/5-HT2B antagonists

Promising data reported from pilot trial of Lubricoat Gel for adhesions

Pharmacia & Upjohn describes agents for 5-HT1A receptor-mediated disorders

Houghten changes name to Trega Biosciences

FDA clears Gull's new Toxoplasma ELISA test

Excitatory amino acid antagonists from Novartis

Retroviral protease inhibitors disclosed by DuPont Merck

Pfizer describes substance P antagonists

Celgene reports dual TNF/PDE inhibitors

American Home Products develops agents for diabetes and diabetic complications

U.S. patent allowance related to BioTransplant's XenoMune technology

New antiulcer agents from Fujisawa

Genome Therapeutics and Creighton University pursue genes associated with osteoporosis

DuPont Merck presents new thrombin inhibitor

New fibrinogen antagonist from DuPont Merck

Dual TxA2/LT receptor antagonist selected for development by Yamanouchi

Preclinical and clinical data on p53 presented at AACR

Biovail's Tiazac approved and introduced in Canada

FDA clears new bladder cancer test

Genesys Pharma/Novopharm Biotech agreement provides funding for antisense drug for AIDS

Telomerase detection for bladder/prostatic cancer highlighted at AUA meeting

Immtech obtains exclusive rights to novel antimicrobial pharmaceutical compounds

Virus Research Institute's Adjumer vaccine delivery system completes phase I

New cell adhesion inhibitor from Biogen

Rhone-Poulenc Rorer's ebastine now available in The Netherlands

Pfizer characterizes new antipsychotic agent

FDA accepts Wyeth-Ayerst's application seeking approval for rotavirus vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...